Addpharma Inc.
Clinical trials sponsored by Addpharma Inc., explained in plain language.
-
New cholesterol combo drug passes early safety check in 60 volunteers
Disease control CompletedThis early-stage study tested a new drug called AD-228A in 60 healthy adults to see how the body absorbs and processes it. The drug is designed to lower high cholesterol. Participants received a single dose of the new drug or a combination of two existing drugs to compare safety …
Phase: PHASE1 • Sponsor: Addpharma Inc. • Aim: Disease control
Last updated May 17, 2026 04:14 UTC
-
Healthy volunteers help test new high blood pressure drug combo
Knowledge-focused CompletedThis early-stage study tested a new drug called AD-227 in 70 healthy adults to see how the body processes it and if it is safe. Participants received a single dose of either the combined drug or its two parts separately. The goal was to gather information, not to treat high blood…
Phase: PHASE1 • Sponsor: Addpharma Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 04:15 UTC
-
Healthy volunteers test two versions of stomach ulcer medicine
Knowledge-focused CompletedThis study tested two different versions of a drug (AD-115A and AD-1151) for stomach ulcers in 46 healthy adults. The goal was to see how the body processes each version and to check for any safety concerns. Participants received a single dose of each drug in a random order, and …
Phase: PHASE1 • Sponsor: Addpharma Inc. • Aim: Knowledge-focused
Last updated May 12, 2026 13:44 UTC